Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
AVXL · against 122 other Healthcare companies of similar size
Ranked #9 of 123 · scores higher than 93% of peers · safety percentile 96
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)18 peers with a safety percentile of 90–100, including AVXL · Click a bar to see the companies
Mainly thanks to its current ratio, which is stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | AVXL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 108 reported | Not reported | 0.22× | — | — | 33% |
| BetaLower is better · 117 reported | 1.14 | 0.64 | 25% | 33% | |
| Current ratioHigher is better · 123 reported | 15.62× | 3.03× | 91% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 165M USD | 99 | 50 | |
| 3 | 284M AUD (≈$188M) | 98 | 36 | |
| 4 | 8.4B JPY (≈$57M) | 98 | ||
| 5 | 213M USD | 98 | ||
| 6 | 5.7B TWD (≈$177M) | 97 | 65 | |
| 7 | 207M USD | 97 | 41 | |
| 8 | 1.1B NOK (≈$105M) | 96 | 58 | |
| 9 | 111M USD | 96 | ||
| 10 | 216M USD | 95 | 44 | |
| 11 | 215M USD | 94 | 34 | |
| 12 | 83.4B KRW (≈$60M) | 93 | 36 | |
| 13 | 184M USD | 92 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score